Correlation Between Elisa Oyj and Herantis Pharma

Can any of the company-specific risk be diversified away by investing in both Elisa Oyj and Herantis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elisa Oyj and Herantis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Elisa Oyj and Herantis Pharma Oyj, you can compare the effects of market volatilities on Elisa Oyj and Herantis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elisa Oyj with a short position of Herantis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elisa Oyj and Herantis Pharma.

Diversification Opportunities for Elisa Oyj and Herantis Pharma

-0.1

Correlation Coefficient

Elisa Oyj  Herantis Pharma

Good diversification

The 3 months correlation between Elisa and Herantis is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Elisa Oyj and Herantis Pharma Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Herantis Pharma Oyj and Elisa Oyj is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elisa Oyj are associated (or correlated) with Herantis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Herantis Pharma Oyj has no effect on the direction of Elisa Oyj i.e., Elisa Oyj and Herantis Pharma go up and down completely randomly.

Pair Corralation between Elisa Oyj and Herantis Pharma

Assuming the 90 days trading horizon Elisa Oyj is expected to under-perform the Herantis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Elisa Oyj is 2.59 times less risky than Herantis Pharma. The stock trades about -0.14 of its potential returns per unit of risk. The Herantis Pharma Oyj is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  144.00  in Herantis Pharma Oyj on September 29, 2024 and sell it today you would earn a total of  5.00  from holding Herantis Pharma Oyj or generate 3.47% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Elisa Oyj  vs.  Herantis Pharma Oyj

Elisa Oyj

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elisa Oyj has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Herantis Pharma Oyj

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Herantis Pharma Oyj are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, Herantis Pharma is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Elisa Oyj and Herantis Pharma

The main advantage of trading using opposite Elisa Oyj and Herantis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elisa Oyj position performs unexpectedly, Herantis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Herantis Pharma will offset losses from the drop in Herantis Pharma's long position.

The idea behind Elisa Oyj and Herantis Pharma Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.